Civik Thomas bought PYXS
August 12, 2026 · Form 4 insider transaction
Civik Thomas bought 250,956 shares of Pyxis Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
250,956
Price
$0.00
Total value
N/A
InsiderCivik Thomas
RoleOfficer, Director
CompanyPyxis Oncology, Inc. (PYXS)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after941,087
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the performance-based portion of an option that was granted on February 3, 2026, which shares subject to this portion of the option were to become vested in full upon the completion of a successful financing transaction or a successful strategic transaction during the reporting person's continued service as Interim Chief Executive Officer or within six months thereafter. The performance conditions were deemed to have been met on August 12, 2026, as determined by the Board.